Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Bone Monitoring Guidelines in Gaucher Disease Video

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyp mystery

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Evaluation of lipid management following ACS

Maternal and Perinatal Outcomes of VTE

Use of Lipid-Lowering Therapies Over 2 Years

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Perceptions and Barriers on the use of PCSK9 inhibitors

Recurrence of VTE in Patients with Recent Gestational DVT or PE

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the Safeheart registry